Every unstoppable journey is unique 🌟 and Sara Grega’s path is a testament to her curiosity, understanding of people, and the power of embracing unique growth opportunities. Starting at an Omnicom creative agency in HR, and moving to a career in dental hygiene for 5 years, and then back to Omnicom Health in Learning & Development, Sara's unique background has been key to her continued success. Now, as a Director within the Talent Development & Organizational Growth team, she drives innovation through network learning programs, EQ coaching, and more—proving that when we embrace our unique paths, there’s no limit to what we can achieve. 🚀 #OmnicomHealth #UniquelyPowerful #TogetherUnstoppable #UnstoppableJourneys
About us
The next big thing in health starts here—where bold ideas, deep expertise, and powerful partnerships converge. At Omnicom Health, we’re the world’s largest, most multi-specialty healthcare communications network—uniting leading agencies across every stage of the healthcare journey, from discovery to access, awareness to action. Each brings distinct strengths. But when we work together, we unlock transformative technology, data-driven insights, and smarter, faster ways to drive better outcomes for all. We don’t just respond to change—we drive it. With a shared purpose and unmatched capabilities, we’re shaping a healthier, more connected world. Let’s build what’s next—together.
- Website
-
http://www.omnicomhealthgroup.com/
External link for Omnicom Health
- Industry
- Marketing Services
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, NY
- Type
- Public Company
Locations
Employees at Omnicom Health
-
Josef Valu
Art Director (Group Art Sup/ACD/UX/UI) Healthcare | Pharma | Advertising | Marketing | Entertainment
-
David Cohen
Award-winning Content Director | Manager & Group Video Lead | Mentor | Driving Innovation | Stylish Content Creator | Motion Designer | Music Nerd
-
Kevin Fong
-
Alice Tang
Art Direction / UX & Design
Updates
-
🚨 New POV Drop: ESMO 2025 — From Breakthroughs to Balance One month after ESMO 2025, the impact is still unfolding. From AI in the clinic, to breakthrough science, to how the oncology community engages online — the landscape is evolving faster than ever. To capture the full picture, we brought together three perspectives from across the Omnicom network: 🤖 Dee Parker (Healthcare Consultancy Group - HCG) — AI’s accelerating role in clinical workflows, decision-making, and cancer center operations 🔬 Lisa O'Sullivan (Omnicom PR Group (OPRG) EMEA Health Lead) — the science, the signals, and the storytelling shaping oncology’s next chapter 📈 Joe Milner(Porter Novelli London) — the traditional + social media trends that defined what people talked about and why 📘 Read the full piece on The Next Big Thing: https://lnkd.in/ew8QdZEq #ESMO2025 #Oncology #OmnicomHealth #OPRG #TheNextBigThing #ThoughtLeadership #AIinHealthcare #OncologyMarketing
-
💌 Our Postcards from Health series continues — bringing lived experiences, cultural insights, and local healthcare perspectives from across our global network into the health marketing dialogue. This latest postcard comes from the United Kingdom 🇬🇧, where Tracey Brader CSIO at DDB Remedy London, explores how the rise of weight-loss drugs has revealed something bigger about creativity in constraint. In this postcard, Tracey reflects on how the UK’s healthcare system — with its pride, structure, and strict limitations — has inspired fresh thinking, private innovation, and new ways to reach patients when direct-to-consumer advertising isn’t an option. 👉 Read the full piece: https://lnkd.in/ew8QdZEq Follow along for more postcards, more voices, and more perspectives from around the world 🌍 #PostcardsFromHealth #UK #NextBigThing #OmnicomHealth #ThoughtLeadership #HealthcareMarketing #Innovation #TogetherUnstoppable
-
Omnicom Health reposted this
🚨 New POV Drop: Inside the Psychology of Impact “Impact” has become one of healthcare’s favorite words, but achieving it takes more than metrics. In our latest Healthy Dose POV, authored by Nicole Ann Collins (Omnicom Health) and based on the MAPS-published article The Psychology of Impact in Pharma by Isaac Bruce and Stephen Towers, PhD (Healthcare Consultancy Group - HCG) and Matthew Figler and Kathleen King, PCC (Omnicom Health), we explore the human side of impact — how psychology, mindset, and motivation shape how organizations define, measure, and sustain progress. 💭 Why we hesitate to change and how psychological safety enables innovation 🧩 How the SCARF model helps decode team behavior 🔄 Three steps to build more resilient, impact-driven teams The takeaway: True impact starts with people. By fostering experimentation, autonomy, and psychological safety, we can move from intention to measurable change. 📄 Read the full Healthy Dose: www.bethecasestudy.com 👏 Special thanks to Isaac, Matt, Kathleen, and Stephen for their insights and collaboration. #OmnicomHealth #HCG #Impact #Leadership #HealthcareInnovation #TheNextBigThing #ThoughtLeadership #UniquelyPowerful #TogetherUnstoppable
-
Every unstoppable journey takes its own shape—and Michelle Alford-Peters’s path is all about people, growth, and building what’s next. After a decade in wealth management, Michelle joined Entrée Health during a time of transformation. With Omnicom Health’s support, she brought leadership’s vision to life, creating a new department of Account Managers to champion client finances and connect teams with high-level analytics. Four years in, as VP of Business Operations, Michelle continues to learn, lead, and thrive, proving that true leadership is rooted in a passion for helping others grow. 💙 #OmnicomHealth #UniquelyPowerful #TogetherUnstoppable #UnstoppableJourneys
-
-
🚨 New POV Drop: Inside the Psychology of Impact “Impact” has become one of healthcare’s favorite words, but achieving it takes more than metrics. In our latest Healthy Dose POV, authored by Nicole Ann Collins (Omnicom Health) and based on the MAPS-published article The Psychology of Impact in Pharma by Isaac Bruce and Stephen Towers, PhD (Healthcare Consultancy Group - HCG) and Matthew Figler and Kathleen King, PCC (Omnicom Health), we explore the human side of impact — how psychology, mindset, and motivation shape how organizations define, measure, and sustain progress. 💭 Why we hesitate to change and how psychological safety enables innovation 🧩 How the SCARF model helps decode team behavior 🔄 Three steps to build more resilient, impact-driven teams The takeaway: True impact starts with people. By fostering experimentation, autonomy, and psychological safety, we can move from intention to measurable change. 📄 Read the full Healthy Dose: www.bethecasestudy.com 👏 Special thanks to Isaac, Matt, Kathleen, and Stephen for their insights and collaboration. #OmnicomHealth #HCG #Impact #Leadership #HealthcareInnovation #TheNextBigThing #ThoughtLeadership #UniquelyPowerful #TogetherUnstoppable
-
Omnicom Health reposted this
𝘞𝘩𝘦𝘳𝘦 𝘪𝘴 𝘱𝘩𝘢𝘳𝘮𝘢 𝘣𝘳𝘢𝘯𝘥 𝘮𝘢𝘳𝘬𝘦𝘵𝘪𝘯𝘨 𝘢𝘯𝘥 𝘤𝘶𝘴𝘵𝘰𝘮𝘦𝘳 𝘦𝘯𝘨𝘢𝘨𝘦𝘮𝘦𝘯𝘵 𝘩𝘦𝘢𝘥𝘪𝘯𝘨? Our Strategy Partner Yavuz Dilmac shares key takeaways from this year’s Reuters Pharma Customer Engagement Europe 2025 - where AI, creativity, and collaboration took centre stage. From Agentic AI and unified engagement to reimagined brand growth and co-creation with real customers, Yavuz explores how technology and human insight are converging to shape the future of healthcare marketing. Dive into his full reflections below - a must-read for anyone rethinking how pharma connects with HCPs, patients, and payers. #PharmaMarketing #CustomerEngagement #HealthcareStrategy #DDBRemedy #RECustomerEU
Where is pharma brand marketing and customer engagement heading? Here’s my take after two days surrounded by the industry’s key players at Reuters Events Pharma Customer Engagement Europe 2025 — where AI, creativity, and collaboration collided. 1. The AI hype is clear — but the direction isn’t. Agentic AI, human-in-the-loop systems, and the so-called shift from B2B to A2A (Agent to Agent) were hot topics. We’re talking about a future where AI augments marketing, co-pilots decision-making, and shapes compliant customer conversations in real time. And GEO is the new SEO. As global search moves to LLMs like ChatGPT, the industry is exploring compliant ways to influence generative AI responses towards customers. Conversational interfaces are expected to become mainstream for pharma web experiences - both for external customers and for internal use cases including field force training. 2. The “unified customer engagement” movement is gaining pace. Across commercial, medical, and access, everyone agrees on the why — fewer silos, better coordination, more value for customers. But the how still varies wildly. Some pioneers are testing shared roles, cross-functional training, and single points of contact for healthcare professionals. It’s early days, but the industry seems more serious than ever about breaking old organisational habits. 3. Measuring effectiveness is the new obsession. The question isn’t if we’re engaging customers — it’s how well. From Marketing Mix Modelling (MMM) to smarter success metrics, brands are rethinking how they define their success. It’s less about reach, more about relevance — and whether engagement actually changes behaviour. 4. “Optichannel” didn’t quite stick. The term got a collective eye-roll since optimisation is already part of omnichannel marketing. But everyone agreed that true optimisation is still rare. The ambition remains: make omnichannel meaningful, measurable, and genuinely customer-driven. 5. Pharma’s approach to brand growth is being reimagined, drawing fresh inspiration from both B2C and B2B marketing. Just giving your trial data to customers through sales reps won’t make the cut anymore. ‘Distinction’ over ‘differentiation’ and how to generate ‘mental availability’ through creativity and emotional resonance are being discussed as CX and brand marketing become inseparable. 6. Real co-creation is paying off. Beyond market research, teams are embracing a ‘service design’ approach, co-developing with HCPs, patients, and payers. It’s refreshing — and far more effective — to solve real problems with real customers instead of hypothesising in internal echo chambers. Obviously, my (and our agency’s) views on these topics go deeper than a single post — if any of this resonates, I’d love to continue the conversation. Drop me a message! #REcustomerEU #CustomerExperience #PharmaMarketing
-
-
Where is pharma brand marketing and customer engagement headed next? Our colleague Yavuz Dilmac, Strategy Partner at DDB Remedy London, recently attended Reuters Pharma Customer Engagement Europe 2025, where AI, creativity, and collaboration took center stage. In his reflections, Yavuz explores how Agentic AI, unified engagement, and co-creation with real customers are redefining how pharma connects with HCPs, patients, and payers. We’re proud to see voices across the Omnicom Health network leading the conversation on the future of healthcare marketing. 👉 Read Yavuz’s full post below. #PharmaMarketing #CustomerEngagement #HealthcareStrategy #OmnicomHealth #RECustomerEU” #UniquelyPowerful #TogetherUnstoppable
Where is pharma brand marketing and customer engagement heading? Here’s my take after two days surrounded by the industry’s key players at Reuters Events Pharma Customer Engagement Europe 2025 — where AI, creativity, and collaboration collided. 1. The AI hype is clear — but the direction isn’t. Agentic AI, human-in-the-loop systems, and the so-called shift from B2B to A2A (Agent to Agent) were hot topics. We’re talking about a future where AI augments marketing, co-pilots decision-making, and shapes compliant customer conversations in real time. And GEO is the new SEO. As global search moves to LLMs like ChatGPT, the industry is exploring compliant ways to influence generative AI responses towards customers. Conversational interfaces are expected to become mainstream for pharma web experiences - both for external customers and for internal use cases including field force training. 2. The “unified customer engagement” movement is gaining pace. Across commercial, medical, and access, everyone agrees on the why — fewer silos, better coordination, more value for customers. But the how still varies wildly. Some pioneers are testing shared roles, cross-functional training, and single points of contact for healthcare professionals. It’s early days, but the industry seems more serious than ever about breaking old organisational habits. 3. Measuring effectiveness is the new obsession. The question isn’t if we’re engaging customers — it’s how well. From Marketing Mix Modelling (MMM) to smarter success metrics, brands are rethinking how they define their success. It’s less about reach, more about relevance — and whether engagement actually changes behaviour. 4. “Optichannel” didn’t quite stick. The term got a collective eye-roll since optimisation is already part of omnichannel marketing. But everyone agreed that true optimisation is still rare. The ambition remains: make omnichannel meaningful, measurable, and genuinely customer-driven. 5. Pharma’s approach to brand growth is being reimagined, drawing fresh inspiration from both B2C and B2B marketing. Just giving your trial data to customers through sales reps won’t make the cut anymore. ‘Distinction’ over ‘differentiation’ and how to generate ‘mental availability’ through creativity and emotional resonance are being discussed as CX and brand marketing become inseparable. 6. Real co-creation is paying off. Beyond market research, teams are embracing a ‘service design’ approach, co-developing with HCPs, patients, and payers. It’s refreshing — and far more effective — to solve real problems with real customers instead of hypothesising in internal echo chambers. Obviously, my (and our agency’s) views on these topics go deeper than a single post — if any of this resonates, I’d love to continue the conversation. Drop me a message! #REcustomerEU #CustomerExperience #PharmaMarketing
-
-
We’re excited to introduce Unstoppable Journeys, a new series celebrating the unique paths that make Omnicom Health such a powerful network. 🌍 Whether you started outside healthcare, moved between agencies, or discovered a new discipline along the way, there’s no single route to success here, only opportunities to grow, learn, and thrive. 🌱 Meet Luis Cortes, PROPELLER’s first-ever dedicated Data Analyst. 💻 Once a total newcomer to healthcare, Luis has quickly become a key part of Propeller’s growth story. Through hands-on training from our IT and Digital Engagement teams, he now helps uncover the insights that drive stronger connections with the patients we serve. 💡 #OmnicomHealth #UniquelyPowerful #TogetherUnstoppable #UnstoppableJourneys
-
-
🚨 New POV Drop: The Future Is Direct — How Telemedicine Is Redefining Pharma Access A new policy shift is accelerating direct-to-consumer (DTC) and direct-to-patient (DTP) models—reshaping how therapies are marketed, priced, and delivered. In our latest Next Big Thing POV, Kevin Cast (Partner, Archbow Consulting) breaks down: 💡 What the rise of DTC/DTP means for the future of patient access ⚙️ Four critical success areas for navigating this new landscape 🌐 Why telemedicine is the connective force linking awareness, access, and adherence The takeaway: Brands that move fastest to modernize access models—and design for patients, not just prescriptions—will define the next era of healthcare innovation. 📄 Read the full POV: https://lnkd.in/ew8QdZEq #OmnicomHealth #Archbow #UniquelyPowerful #TogetherUnstoppable #HealthcareAccess #ThoughtLeadership #TheNextBigThing #Telemedicine #PatientJourney #MarketAccess